Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 1, 2005Cancer Epidemiology Biomarkers & Prevention

A Prospective Study of the Insulin-Like Growth Factor Axis in Relation with Prostate Cancer in the SU.VI.MAX Trial

View Full Paper
Ask AI
Bookmark
Share

Authors

FMFrançois MeyerZoological Society of LondonPGPilar GalánUniversité Paris-SudPDPierre DouvilleOntario Institute for Cancer Research

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Meyer et al. (2005) studied this question.

synapsesocial.com/papers/6aaa16f8b5e32d7ae65591b7https://doi.org/10.1158/1055-9965.epi-05-0303
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Insulin-like growth factors (IGF-I, free IGF-I, and IGF-II) and insulin-like growth factor binding proteins (IGFBP-2, IGFBP-3, IGFBP-6, and ALS) in blood circulation1999 · 187 citations
  2. 2Plasma Insulin-Like Growth Factor-I, Insulin-Like Growth Factor-Binding Proteins, and Prostate Cancer Risk: a Prospective Study2000 · 403 citations
  3. 3Insulin-Like Growth Factor-I (IGF-I) and IGF Binding Protein-3 as Predictors of Advanced-Stage Prostate Cancer2002 · 436 citations
  4. 4Elevated levels of insulin-like growth factor-binding protein-2 in the serum of prostate cancer patients.1993 · 202 citations
  5. 5Serum Levels of Insulin-Like Growth Factor I (IGF-I), IGF-II, IGF-Binding Protein-3, and Prostate-Specific Antigen as Predictors of Clinical Prostate Cancer2000 · 218 citations